Dual molecular therapy targeting tumor cell heterogeneity improves therapeutic efficacy in glioblastoma. [PDF]
Hirano S +20 more
europepmc +1 more source
Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas. [PDF]
Sears TK +7 more
europepmc +1 more source
The Dual Role of Human UDP-Glucuronosyltransferase-Mediated Metabolism in Tumor Drug Resistance: Mechanisms and Prospects. [PDF]
Wang Z +8 more
europepmc +1 more source
Protocol for enhancing CRISPR-Cas9 genome editing using histone deacetylase inhibition and engineered virus-like particle delivery. [PDF]
Djamshidi M +6 more
europepmc +1 more source
Polyfunctionalized <i>N</i>-Arylsulfonyl Indoles: Identification of (<i>E</i>)-<i>N</i>-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1<i>H</i>-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease. [PDF]
Toledano-Pinedo M +27 more
europepmc +1 more source
Protein domain movement involved in binding of belinostat and HPOB as inhibitors of histone deacetylase 6 (HDAC6): a hybrid automated-interactive docking study. [PDF]
Iakovou G +5 more
europepmc +1 more source
scBalFlow: a staged flow matching framework for imbalanced single-cell drug perturbation prediction. [PDF]
Lyu H, Luo J.
europepmc +1 more source
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma. [PDF]
Saeed H +15 more
europepmc +1 more source
Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities. [PDF]
Chen S, He Q, He Y, Jin J, Wen A.
europepmc +1 more source

